Literature DB >> 6199055

A functional assay of protein C in human plasma.

N Sala, W G Owen, D Collen.   

Abstract

A three-step spectrophotometric assay was developed for measuring functional protein C (PC) in human plasma. The assay is based on: (1) adsorption of citrated platelet-poor plasma on barium citrate and elution of the vitamin K-dependent factors with EDTA; (2) activation of PC by incubation of the mixture of vitamin K-dependent factors with a complex of thrombin and its endothelial cell cofactor, thrombomodulin; (3) addition of antithrombin III and heparin to the system to inhibit thrombin and other coagulation enzymes generated during incubation and measurement of the activated PC with a synthetic (chromogenic) substrate. The assay appears to be specific for PC because: (a) PC-depleted plasma (by immunoadsorption) is inactive; (b) addition of purified PC to PC-depleted plasma reconstitutes its activity; and (c) no enzymatic activity is generated in the absence of the thrombin-thrombomodulin complex. Mixtures of a normal plasma pool with PC-depleted plasma yielded an amount of enzymatic activity proportional to the fraction of normal plasma. Using this as a standard curve, the amount of PC in the plasma of 23 normal subjects was 97% +/- 15%. The within-assay coefficient of variation was 3.5% and the between-assay coefficient 6.5%. A linear correlation (r = 0.86) was found between PC as measured with the functional assay and with a radioimmunoassay. In 3 patients with congenital PC deficiency, the functional PC level was 37% +/- 9% and the antigen level 64% +/- 11%. It is concluded that the present assay may be used for reliable and accurate estimation of activatable PC in human plasma.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199055

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  10 in total

1.  Up-regulation of thrombomodulin by activation of histamine H1-receptors in human umbilical-vein endothelial cells in vitro.

Authors:  K Hirokawa; N Aoki
Journal:  Biochem J       Date:  1991-06-15       Impact factor: 3.857

2.  Relationship between protein C antigen and anticoagulant activity during oral anticoagulation and in selected disease states.

Authors:  S Vigano D'Angelo; P C Comp; C T Esmon; A D'Angelo
Journal:  J Clin Invest       Date:  1986-02       Impact factor: 14.808

3.  Genetic variants associated with protein C levels.

Authors:  C Y Vossen; B P Koeleman; S J Hasstedt; I J Nijman; I J Renkens; P W Callas; F R Rosendaal; E G Bovill
Journal:  J Thromb Haemost       Date:  2013-04       Impact factor: 5.824

4.  Locating the rate-determining step(s) for three-step hydrolase-catalyzed reactions with DYNAFIT.

Authors:  Daoning Zhang; Ildiko M Kovach; John Paul Sheehy
Journal:  Biochim Biophys Acta       Date:  2008-03-10

Review 5.  Clinical relevance of protein C.

Authors:  I Pabinger
Journal:  Blut       Date:  1986-08

6.  Specificity of activated human protein C.

Authors:  S R Stone; J Hofsteenge
Journal:  Biochem J       Date:  1985-09-01       Impact factor: 3.857

7.  A simplified functional assay for protein C in plasma samples.

Authors:  W Thiel; K T Preissner; U Delvos; G Müller-Berghaus
Journal:  Blut       Date:  1986-03

8.  Influence of protein C activation on blood coagulation and fibrinolysis in squirrel monkeys.

Authors:  M Colucci; J M Stassen; D Collen
Journal:  J Clin Invest       Date:  1984-07       Impact factor: 14.808

9.  Detection of thrombomodulin in human lung cancer cells.

Authors:  A Tamura; O Matsubara; K Hirokawa; N Aoki
Journal:  Am J Pathol       Date:  1993-01       Impact factor: 4.307

10.  [Immunologic and functional protein C determination in various internal diseases].

Authors:  K H Zurborn; H Broers; W Kirch; N Jäger; H D Bruhn
Journal:  Klin Wochenschr       Date:  1987-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.